BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11388719)

  • 1. Significant FDA approvals in 2000.
    McGinnis TJ
    Am Fam Physician; 2001 May; 63(10):2061-4. PubMed ID: 11388719
    [No Abstract]   [Full Text] [Related]  

  • 2. Making medical progress. A look at FDA approvals in 2000.
    FDA Consum; 2001; 35(2):7-8. PubMed ID: 11444251
    [No Abstract]   [Full Text] [Related]  

  • 3. Significant FDA approvals in 2001.
    McGinnis TJ
    Am Fam Physician; 2002 Jun; 65(11):2377-8, 2380, 2383. PubMed ID: 12074535
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA new drug approvals in 2003.
    Wynn RL
    Gen Dent; 2004; 52(4):294-8, 300. PubMed ID: 15366292
    [No Abstract]   [Full Text] [Related]  

  • 5. The year in review. A panoply of product approvals.
    Nordenberg T
    FDA Consum; 2000; 34(3):10-2. PubMed ID: 11521248
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA begins product approval initiative.
    Lewis C
    FDA Consum; 2003; 37(3):10-1. PubMed ID: 12793386
    [No Abstract]   [Full Text] [Related]  

  • 7. 2007 FDA drug approvals: a year of flux.
    Hughes B
    Nat Rev Drug Discov; 2008 Feb; 7(2):107-9. PubMed ID: 18246607
    [No Abstract]   [Full Text] [Related]  

  • 8. 2011 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2012 Feb; 11(2):91-4. PubMed ID: 22293555
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA shortened drug approval time in 1995.
    Public Health Rep; 1996; 111(4):290. PubMed ID: 8711090
    [No Abstract]   [Full Text] [Related]  

  • 10. Significant FDA approvals in 1996.
    Rheinstein PH
    Am Fam Physician; 1997 Jun; 55(8):2855-8. PubMed ID: 9191461
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA science: from concept to consumer.
    Rados C
    FDA Consum; 2004; 38(3):10-1. PubMed ID: 15218837
    [No Abstract]   [Full Text] [Related]  

  • 12. Significant FDA approvals in 1994.
    Rheinstein PH
    Am Fam Physician; 1995 Mar; 51(4):888-90. PubMed ID: 7887364
    [No Abstract]   [Full Text] [Related]  

  • 13. Significant FDA approvals in 1995.
    Rheinstein PH
    Am Fam Physician; 1996 Apr; 53(5):1871-4. PubMed ID: 8623703
    [No Abstract]   [Full Text] [Related]  

  • 14. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 15. Significant FDA approvals in 1997.
    Rheinstein PH; Akbari B
    Am Fam Physician; 1998 Jun; 57(11):2865-8. PubMed ID: 9636343
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA drug approvals from 1994 to 1995.
    Wynn RL
    Gen Dent; 1996; 44(2):114, 116, 118. PubMed ID: 8690259
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA drug approvals in 1993-94.
    Wynn RL
    Gen Dent; 1995; 43(1):12, 14. PubMed ID: 7758913
    [No Abstract]   [Full Text] [Related]  

  • 18. New drug approvals for 2002.
    Frantz S; Smith A
    Nat Rev Drug Discov; 2003 Feb; 2(2):95-6. PubMed ID: 12572538
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.